Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 6/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30475147 | 1.00 | NAAA (0.48) | NAAACES2EPHX1TSHRCES1 | |
| SCHEMBL30528029 | 1.00 | NAAA (0.48) | NAAACES2EPHX1TSHRCES1 | |
| SCHEMBL30801423 | 1.00 | NAAA (0.48) | NAAACES2EPHX1TSHRCES1 | |
| SCHEMBL2690623 | 1.00 | NAAA (0.48) | NAAACES2EPHX1TSHRCES1 | |
| SCHEMBL30475146 | 1.00 | NAAA (0.48) | NAAACES2EPHX1TSHRCES1 | |
| SCHEMBL2689547 | 0.98 | NAAA (0.46) | NAAACES2EPHX1TSHRCES1 | |
| SCHEMBL30655849 | 0.95 | NAAA (0.47) | NAAACES2EPHX1TSHRCES1 | |
| SCHEMBL30655745 | 0.95 | NAAA (0.47) | NAAACES2EPHX1TSHRCES1 | |
| SCHEMBL5163852 | 0.93 | NAAA (0.46) | NAAACES2EPHX1TSHRCES1 | |
| SCHEMBL31272734 | 0.93 | NAAA (0.46) | NAAACES2EPHX1TSHRCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250041318-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | COMMUNITREAT LTD. (IL) | 2025-02-06 | — | — | US | disclosed |
| EP-4440698-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | Communitreat Ltd. (IL) | 2024-10-09 | — | — | EP | disclosed |
| CN-118742312-A | Sterilant compositions, kits and methods of use thereof | 柯姆尼治疗公司 | 2024-10-01 | — | — | CN | disclosed |
| WO-2023100184-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | COMMUNITREAT LTD. (IL) | 2023-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041318-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | NASP, ACR, ALPG | NAAA 4093/4885CES2 3830/4885EPHX1 3702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.